IPO - GeoVax Labs, Inc.

Form Type: POS AM

Filing Date: 2025-03-27

Corporate Action: Ipo

Type: Update

Accession Number: 000143774925009630

Filing Summary: GeoVax Labs, Inc. has filed a Post-Effective Amendment No. 1 to its Registration Statement on Form S-1 with the SEC regarding the registration of 975,610 shares of Common Stock. This filing updates the original registration which was declared effective on September 13, 2024, to include additional information from the previous statement. The registration is associated with warrants issued during a private placement on August 30, 2024. No new securities are being registered under this amendment, and all registration fees have been previously paid. The company continues to emphasize the risks associated with investing in their securities, including a high degree of risk due to their operating losses and reliance on government funding for their lead clinical programs.

Document Link: View Document

Form Type: POS AM

Filing Date: 2025-03-27

Corporate Action: Ipo

Type: Update

Accession Number: 000143774925009631

Filing Summary: GeoVax Labs, Inc. is filing a Post-Effective Amendment No. 1 to their Registration Statement on Form S-1, indicating an intention to conduct an IPO of 1,700,000 shares of common stock. This registration amendment is being filed following the original registration statement, which received effectiveness from the SEC on September 13, 2024. The shares being registered are related to warrants issued in a private placement conducted by the company in August 2024. The company will not receive proceeds from the sale of shares by the Selling Stockholder, as all proceeds will be directed to them, but does expect to receive proceeds from any cash exercises of the common warrants.

Document Link: View Document